A detailed history of Tfc Financial Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Tfc Financial Management holds 3,880 shares of NVO stock, worth $398,204. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,880
Previous 3,845 0.91%
Holding current value
$398,204
Previous $548,000 15.88%
% of portfolio
0.07%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$119.07 - $145.42 $4,167 - $5,089
35 Added 0.91%
3,880 $461,000
Q1 2024

Apr 30, 2024

SELL
$102.11 - $135.92 $19,911 - $26,504
-195 Reduced 4.83%
3,845 $493,000
Q3 2023

Oct 23, 2023

BUY
$90.94 - $199.54 $163,237 - $358,174
1,795 Added 79.96%
4,040 $367,000
Q2 2023

Aug 07, 2023

SELL
$155.98 - $172.65 $216,344 - $239,465
-1,387 Reduced 38.19%
2,245 $363,000
Q3 2022

Oct 21, 2022

SELL
$95.28 - $116.93 $8,003 - $9,822
-84 Reduced 2.26%
3,632 $362,000
Q2 2022

Aug 03, 2022

SELL
$103.24 - $121.81 $10,324 - $12,181
-100 Reduced 2.62%
3,716 $414,000
Q1 2022

May 04, 2022

BUY
$93.1 - $112.54 $23,647 - $28,585
254 Added 7.13%
3,816 $424,000
Q4 2021

Feb 02, 2022

BUY
$95.88 - $117.08 $40,749 - $49,759
425 Added 13.55%
3,562 $399,000
Q3 2021

Nov 02, 2021

BUY
$84.42 - $106.62 $13,085 - $16,526
155 Added 5.2%
3,137 $301,000
Q2 2021

Jul 29, 2021

BUY
$67.66 - $84.76 $3,924 - $4,916
58 Added 1.98%
2,982 $250,000
Q1 2021

May 03, 2021

SELL
$67.06 - $75.82 $4,560 - $5,155
-68 Reduced 2.27%
2,924 $197,000
Q4 2020

Feb 10, 2021

BUY
$63.89 - $73.8 $18,911 - $21,844
296 Added 10.98%
2,992 $209,000
Q3 2020

Nov 12, 2020

BUY
$63.69 - $70.22 $171,708 - $189,313
2,696 New
2,696 $187,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Tfc Financial Management Portfolio

Follow Tfc Financial Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfc Financial Management, based on Form 13F filings with the SEC.

News

Stay updated on Tfc Financial Management with notifications on news.